Microbial translocation and B cell dysfunction in human immunodeficiency virus disease

American Journal of Immunology

Volumn 8, Issue 2, 2012, Pages 44-51

  Jiang, Wei ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

B cell; Dysfunction; HIV disease; Lipo Polys Accharide (LPS); Microbial translocation; Toll Like Receptor (TLR); Vaccine

Indexed keywords

ALPHA INTERFERON; DOUBLE STRANDED RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 5;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; DENDRITIC CELL; DISEASE COURSE; ENTERITIS; EX VIVO STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNE DEFICIENCY; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; INFLUENZA; INNATE IMMUNITY; MEASLES; MEMORY CELL; TETANUS; TREATMENT RESPONSE; VIRUS INFECTION;

EID: 84866347481     PISSN: 1553619X     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajavsp.2012.44.51     Document Type: Article

References (84)

1. Abreu, M.T., 2010. Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Nature Rev. Immunol., 10: 131-144. DOI: 10.1038/nri2707
2. Badley, A.D., J.A. McElhinny, P.J. Leibson, D.H. Lynch and M.R. Alderson et al., 1996. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol., 70: 199-206. PMID: 8523526
3. Barton, G.M. and R. Medzhitovm, 2003. Toll-like receptor signaling pathways. Science, 300: 1524-1525. PMID: 12791976
4. Bekeredjian-Ding, I.B., M. Wagner, V. Hornung, T. Giese and M. Schnurr et al., 2005. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J. Immunol., 174: 4043-4050.
5. Bernasconi, N.L., E. Traggiai and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science, 298: 2199-2202. DOI: 10.1126/science.1076071
6. Bernasconi, N.L., N. Onai and A. Lanzavecchia, 2003. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood, 101: 4500-4504. PMID: 12560217
7. Brenchley, J.M., D.A. Price, T.W. Schacker, T.E. Asher and G. Silvestri et al., 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Med., 12: 1365-1371. DOI: 10.1038/nm1511
8. Broliden, K., J. Hinkula, C. Devito, P. Kiama and J. Kimani et al., 2001. Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers. Immunol. Lett., 79: 29-36. PMID: 11595287
9. Brown, S.B. and J. Savill, 1999. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. J. Immunol., 162: 480-485. PMID: 9886423
10. Chirmule, N., N. Oyaizu, C. Saxinger and S. Pahwa. 1994. Nef protein of HIV-1 has B-cell stimulatory activity. AIDS, 8: 733-734. PMID: 8086129
11. Chuang, T.H., J. Lee, L. Kline, J.C. Mathison and R.J. Ulevitch, 2002. Toll-like receptor 9 mediates CpGDNA signaling. J. Leukocyte Biol., 71: 538-544. PMID: 11867692
12. Clerici, M., C. Barassi, C. Devito, C. Pastori and S. Piconi et al., 2002. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the [alpha]-helix of gp41. AIDS, 16: 1731-1741. PMID: 12218383
13. Conge, A.M., K. Tarte, J. Reynes, M. Segondy and J. Gerfaux et al., 1998. Impairment of B-lymphocyte differentiation induced by dual triggering of the Bcell antigen receptor and CD40 in advanced HIV-1-disease. AIDS, 12: 1437-1449.
14. Devito, C., J. Hinkula, R. Kaul, L. Lopalco and J.J. Bwayo et al., 2000b. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS, 14: 1917-1920. PMID: 10997395
15. Devito, C., K. Broliden, R. Kaul, L. Svensson and K. Johansen et al., 2000a. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J. Immunol., 165: 5170-5176. PMID: 11046049
16. Dykhuizen, M., J.L. Mitchen, D.C. Montefiori, J. Thomson and L. Acker et al., 1998. Determinants of disease in the simian immunodeficiency virusinfected rhesus macaque: characterizing animals with low antibody responses and rapid progression. J. General Virol., 79: 2461-2467.
17. Feng, Z., G.R. Dubyak, M.M. Lederman and A. Weinberg. 2006. Cutting edge: human beta defensin 3--a novel antagonist of the HIV-1 coreceptor CXCR4. J. Immunol., 177: 782-786. PMID: 16818731
18. Fukata, M. and M.T. Abreu, 2009. Pathogen recognition receptors, cancer and inflammation in the gut. Curr. Opin. Pharmacol., 9: 680-687. DOI: 10.1016/j.coph.2009.09.006
19. Gasper-Smith, N., D.M. Crossman, J.F. Whitesides, N. Mensali and J.S. Ottinger et al., 2008. Induction of Plasma (TRAIL), TNFR-2, Fas Ligand and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design. J. Virol., 82: 7700-7710. DOI: 10.1128/JVI.00605-08
20. Gaufin, T., M. Pattison, R. Gautam, C. Stoulig and J. Dufour et al., 2009. Effect of B-cell depletion on viral replication and clinical outcome of simian immunodeficiency virus infection in a natural host. J. Virol., 83: 10347-10357. DOI: 10.1128/ JVI.00880-09
21. Giorgi, J.V., Z. Liu, L.E. Hultin, W.G. Cumberland and K. Hennessey et al., 1993. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr., 6: 904-912. PMID: 7686224
22. Grivel, J.C., R.J. Shattock and L.B. Margolis, 2010. Selective transmission of R5 HIV-1 variants: Where is the gatekeeper? J. Trans. Med. 9: S6-s6. DOI: 10.1186/1479-5876-9-S1-S6
23. +T-cell depletion in HIV infection: are we closer to understanding the cause? Nature Med., 8: 319-323. DOI: 10.1038/nm0402-319
24. Guan, Y., M.M. Sajadi, R. Kamin-Lewis, T.R. Fouts and A. Dimitrov et al., 2009. Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America, Mar. 10. USA, Med. Sci., 106: 3952-3957. DOI: 10.1073/pnas.0813392106
25. Hall, H.I., R. Song, P. Rhodes, J. Prejean and Q. An et al., 2008. Estimation of HIV incidence in the United States. JAMA, 300: 520-529. PMID: 18677024
26. Hart, M., A. Steel, S.A. Clark, G. Moyle and M. Nelson et al., 2007. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J. Immunol., 178: 8212-8220. PMID: 17548660
27. He, B., X. Qiao and A. Cerutti, 2004. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J. Immunol., 173: 4479-4491.
28. Holznagel, E., S. Norley, S. Holzammer, C. Coulibaly and R. Kurth. 2002. Immunological changes in simian immunodeficiency virus (SIVagm)-infected African Green Monkeys (AGM): Expanded cytotoxic T lymphocyte, natural killer and B cell subsets in the natural host of SIVagm. J. General Virol., 83: 631-640.
29. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug and B. Jahrsdorfer et al., 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol., 168: 4531-4537. PMID: 11970999
30. Jiang, W., M.M. Lederman, C.V. Harding, B. Rodriguez and R.J. Mohner et al., 2007. TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function. Eur. J. Immunol., 37: 2205-2213. PMID: 17621369
31. Jiang, W., M.M. Lederman, J.R. Salkowitz, B. Rodriguez and C.V. Harding et al., 2005. Impaired monocyte maturation in response to CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially mediated by deficiencies in alpha/beta interferon responsiveness and productivity. J. Virol., 79: 4109-4119. PMID: 15767412
32. Jiang, W., M.M. Lederman, P. Hunt, S.F. Sieg and K. Haley et al., 2009. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis., 199: 1177-1185. PMID: 19265479
33. Katsikis, P.D., M.E. Garcia-Ojeda, J.F. Torres-Roca, I.M. Tijoe and C.A. Smith et al., 1997. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J. Exp. Med., 186: 1365-1372. PMID: 9334376
34. Kazemi-Shirazi, L., C.H. Gasche, S. Natter, A. Gangl and J. Smolen et al., 2002. IgA autoreactivity: A feature common to inflammatory bowel and connective tissue diseases. Clin. Exp. Immunol., 128: 102-109.
35. Krug, A., A. Towarowski, S. Britsch, S. Rothenfusser and V. Hornunget et al., 2001. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol., 31: 3026-3037. PMID: 11592079
36. Lamphier, M.S., C.M. Sirois, A. Verma, D.T. Golenbock and E. Latz. 2006. TLR9 and the recognition of self and non-self nucleic acids. Annals New York Acad. Sci., 1082: 31-43. PMID: 17145922
37. Lamping, N., R. Dettmer, N.W. Schroder, D. Pfeil and W. Hallatschek et al., 1998. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J. Clin. Investigation, 101: 2065-2071. PMID: 9593762
38. Lichtner, M., C. Maranon, P.O. Vidalain, O. Azocar and D. Hanau et al., 2004. HIV type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4 T lymphocytes. AIDS Res. Hum. Retroviruses 20: 175-182. PMID: 15018705
39. Malaspina, A., S. Moir, A.C. DiPoto, J. Ho and W. Wang et al., 2008. CpG oligonucleotides enhance proliferative and effector responses of B Cells in HIV-infected individuals. J. Immunol., 181: 1199-1206.
40. Malaspina, A., S. Moir, S. Kottilil, C.W. Hallahan and L. A. Ehler et al., 2003. Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function. J. Immunol., 170: 5965-5972. PMID: 12794123
41. Mansson, A., M. Adner, U. Hockerfelt and L.O. Cardell. 2006. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation. Immunology, 118: 539-548. PMID: 16780564
42. Mao, H., B.A. Lafont, T. Igarashi, Y. Nishimura and C. Brown et al., 2005. CD8+ and CD20+ lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotype. J. Virol., 79: 14887-14898. DOI: 10.1128/JVI.79.23.14887-14898.2005
43. Martinson, J.A., A. Roman-Gonzalez, A.R. Tenorio, C.J. Montoya and C.N. Gichinga et al., 2007. Dendritic cells from HIV-1 infected individuals are less responsive to Toll-Like Receptor (TLR) ligands. Cellular Immunol., 250: 75-84. PMID: 18334250
44. McCluskie, M.J. and A.M. Krieg, 2006. Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA. Current Top. Microbiol. Immunol., 311: 155-178. DOI: 10.1007/3-540-32636-7_6
45. McKay, P.F., D.H. Barouch, J.E. Schmitz, R.S. Veazey and D.A. Gorgone et al., 2003. Global dysfunction of CD4 T-lymphocyte cytokine expression in simian-human immunodeficiency virus/SIVinfected monkeys are prevented by vaccination. J. Virol., 77: 4695-4702. DOI: 10.1128/JVI.77.8.4695-4702.2003
46. Meier, A., G. Alter, N. Frahm, H. Sidhu and B. Li et al., 2007. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J. Virol., 81: 8180-8191. PMID: 17507480
47. Melmed, G.Y., N. Agarwal, R.W. Frenck, A.F. Ippoliti and P. Ibanez et al., 2010. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am. J. Gastroenterol., 105: 148-154. PMID: 19755964
48. Melvin, A.J. and K.M. Mohan. 2003. Response to immunization with measles, tetanus and Haemophilus influenza type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy. Pediatrics, 111: e641-644. PMID: 12777579
49. Mestecky, J., S. Jackson, Z. Moldoveanu, L.R. Nesbit and R. Kulhavy et al., 2004. Paucity of antigenspecific IgA responses in sera and external secretions of HIV-type 1-infected individuals. AIDS research and human retroviruses 20: 972-988. DOI: 10.1089/aid.2004.20.972
50. Milito, A.D., 2004. B lymphocyte dysfunctions in HIV infection. Curr. HIV Res., 2: 11-21. PMID: 15053337
51. Milito, A.D., A. Nilsson, K. Titanji, R. Thorstensson and E. Reizenstein et al., 2004. Mechanisms of hypergammaglobulinemia and impaired antigenspecific humoral immunity in HIV-1 infectious. Blood, 103: 2180-2186. PMID: 14604962
52. Milito, A.D., B. Hejdeman, J. Albert, S. Aleman, A. Sonnerborg, M. Zazzi and F. Chiodi. 2000. High plasma levels of soluble fas in HIV type 1-infected subjects are not normalized during highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 16: 1379-1384. PMID: 11018857
53. Miller, C.J., M. Genesca, K. Abel, D. Montefiori and D. Forthal et al., 2007. Antiviral antibodies are necessary for control of simian immunodeficiency virus replication. J. Virol., 81: 5024-5035. DOI: 10.1128/JVI.02444-06
54. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji and A. Yachieet et al., 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol., 149: 3753-3758.
55. MMWR, 2006. Epidemiology of HIV/AIDS--United States, 1981-2005. Weekly, 55: 589-592.
56. Moir, S., A. Malaspina, K.M. Ogwaro, E.T. Donoghue and C.W. Hallahan et al., 2001. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proceedings of the National Academy of Sciences of the United States of America. (NASUSA' 01) USA, The National Academy of Sciences, 98: 10362-10367. DOI: 10.1073/pnas.181347898
57. Moir, S., A. Malaspina, O.K. Pickeral, E.T. Donoghue and J. Vasquez et al., 2004. Decreased survival of B cells of HIV-viremic patients mediated by altering expression of receptors of the TNF superfamily. The Journal of experimental medicine 200: 587-599. DOI: 10.1084/ jem. 20032236
58. Moir, S., A. Malaspina, Y. Li, T.W. Chun and T. Lowe et al., 2000. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activate T cells. J. Exp. Med., 192: 637-646. DOI: 10.1084/jem.192.5.637
59. Mueller, Y.M., S.C. De Rosa, J.A. Hutton, J. Witek and M. Roederer et al., 2001. Increased CD95/Fas-Induced Apoptosis of HIV-Specific CD8+ T Cells. Immunity, 15: 871-882. DOI: 10.1016/S1074-7613(01)00246-1
60. Nagase, H., K. Agematsu, K. Kitano, M. Takamoto and Y. Okuboet et al., 2001. Mechanism of hypergammaglobulinemia of HIV infection: circulating memory B-cell reduction with plasmacytosis. Clin. Immunol., 100: 250-259. PMID: 11465955
61. Nunnari, G., Y. Xu, E.A. Acheampong, J. Fang and R. Daniel et al., 2005. Exogenous IL-7 induces Fasmediated human neuronal apoptosis: potential effects during human immunodeficiency virus type 1 infection. J. Neurovirol., 11: 319-328. DOI: 10.1080/13550280500187005
62. O'Neill, L.A., 2000. The interleukin-1 receptor/Tolllike receptor superfamily: Signal transduction during inflammation and host defense. Sci. STKE. PMID: 11752602
63. O'Neill, L.A., 2002a. Toll-like receptor signal transduction and the tailoring of innate immunity: A role of Mal? Trends Immunol., 23: 296-300. PMID: 12072368
64. O'Neill, L.A., 2002b. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Current Top. Microbiol. Immunol., 270: 47-61. PMID: 12467243
65. Pandrea, I.V., R. Gautam, R.M. Ribeiro, J.M. Brenchley and I.F. Butler et al., 2007. Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J. Immunol., 179: 3035-3046. PMID: 17709518
66. Papadimitraki, E.D., C. Choulaki, E. Koutala G. Bertsias and C. Tsatsanis et al., 2006. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: Implications for the induction and maintenance of the autoimmune process. Arthritis Rheum., 54: 3601-3611. PMID: 17075805
67. Petrovas, C., Y. M. Mueller and P. D. Katsikis. 2005. Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy. Cell Death Differ., 12: 859-870. DOI: 10.1038/sj.cdd.4401595
68. Poeck, H., M. Wagner, J. Battiany, S. Rothenfusser and D. Wellisch et al., 2004. Plasmacytoid dendritic cells, antigen and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood, 103: 3058-3064. PMID: 15070685
69. Qiao, X., B. He, A. Chiu, D.M. Knowles and A. Chadburn et al., 2006. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nature Immunol., 7: 302-310. DOI: 10.1038/ni1302
70. Roggenbuck, D., G. Hausdorf, L. Martinez-Gamboa, D. Reinhold and T. Buttner et al., 2009. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease. Gut 58: 1620-1628. DOI: 10.1136/gut.2008.162495
71. Salvato, M.S., C.C. Yin, H. Yagita, T. Maeda and K. Okumura et al., 2007. Attenuated disease in SIVinfected macaques treated with a monoclonal antibody against FasL. Clin. Developmental Immunol., 2007: 93462-934629 DOI: 10.1155/2007/93462
72. Samuelsson, A., C. Brostrom, N. van Dijk, A. Sonnerborg and F. Chiodi. 1997. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load and loss of humoral immunity. Virology 238: 180-188.
73. Schattner, E. and S.M. Friedman, 1996. Fas expression and apoptosis in human B cells. Immunol Res., 15: 246-257. DOI: 10.1007/BF02918252
74. Shen, K.H., C.H. Lin, H.K. Chang, W.C. Chen and S.H. Chen. 2008. Premarin can act via estrogen receptors to rescue mice from heatstroke-induced lethality. Shock, 30: 668-674. DOI: 10.1097/SHK.0b013e31817538cb
75. Soboll, G., L. Shen and C. R. Wira. 2006. Expression of Toll-Like Receptors (TLR) and responsiveness to tlr agonists by polarized mouse uterine epithelial cells in culture. Biology of reproduction 75:131-139. DOI: 10.1095/biolreprod.106.050690
76. Steger, K.K., M. Dykhuizen, J.L. Mitchen, P.W. Hinds and B.L. Preuninger et al., 1998. CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques. J. Virol., 72: 1600-1605.
77. Stylianou, E., A. Yndestad, L.I. Sikkeland, V. Bjerkeli and J.K. Damas et al., 2002. Effects of interferonalpha on gene expression of chemokines and members of the tumor necrosis factor superfamily in HIV-infected patients. Clin. Exp. Immunol., 130: 279-285. PMID: 12390316
78. Swingler, S., B. Brichacek, J. M. Jacque, C. Ulich, J. Zhou and M. Stevenson. 2003. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature, 424: 213-219. PMID: 12853962
79. Terpstra, F.G., B.J. Al, M.T. Roos, F. De Wolf and J. Goudsmit et al., 1989. Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection. Eur. J. Immunol., 19: 667-673. DOI: 10.1002/eji.1830190415
80. Titanji, K., A. De Milito, A. Cagigi, R. Thorstensson and S. Grutzmeier et al., 2006. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood, 108: 1580-1587. PMID: 16645169
81. Titanji, K., F. Chiodi, R. Bellocco, D. Schepis and L. Osorio et al., 2005. Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. AIDS, 19: 1947-1955. DOI: 10.1186/1742-4690-2-S1-P95
82. Tsibris, A.M. and M.S. Hirsch. 2010. Antiretroviral therapy in the clinic. J. Virol., 84: 5458-5464. PMID: 20181709
83. Vollmer, J., R. Rankin, H. Hartmann, M. Jurk and U. Samulowitz et al., 2004. Immunopharmacology of CpG oligodeoxynucleotides and ribavirin. Antimicrobial Agents Chemotherapy, 48: 2314-2317. DOI: 10.1128/AAC.48.6.2314-2317.2004
84. Yoshikai, Y., 2006. Crosstalk between innate and adaptive immunity. Nihon Rinsho, 64: 1223-1228. PMID: 16838637